Skip to Content
Life-Science-PoV_Banner-2880x1800ai
Healthcare

The latest in eco-packaging for a greener pharma industry

Each year, medicine packaging accounts for around one-thousandth of waste produced by French households. A remarkably negligible amount of waste, you might be thinking. But the problem lies not in the amount but the make-up of the packaging. As such, pharmaceutical companies now see eco-packaging as a great way to better align their operations with sustainability targets.

In our latest publication, we at Capgemini take a closer look at the differences between European and American initiatives and how well they achieve their goals. From this Point of View, we examine industry-leading case studies, compare sectors, and analyze the use of emerging innovative materials.

Thought Leadership

This report investigates eco-packaging for the pharma industry, including primary packagings like blisters, tubes, vials, ampoules, syringes and secondary packaging like boxes, leaflets and labels, trays.

Download the report

Fill out the details to download the report

Thank You! We have received your form submission.

We are sorry, the form submission failed. Please try again.

Our Experts

Broderick Jones

Global Head of Life Science & Med Tech, Capgemini Invent
Broderick brings extensive Life Science and Healthcare experience to each client engagement with the goal of driving top-line growth and building capabilities for ongoing commercial success and cost management. His track record of developing high quality business strategies and transformation plans has driven unparalleled customer experience and internal operational excellence globally.

Damien Vossion

Vice President at Capgemini Invent, Life Sciences & Operating Model
I started my career as a consultant in 2000 and gained experience in major transformation projects in Manufacturing, Quality, Supply Chain, and clinical operations, with a strong focus on Industry 4.0 since 2015. I supported General Management in the Life Sciences sector (Pharmaceutical companies, Medical Device companies, and Chemical companies) as well as other large industrial and services companies. I now manage the Life Sciences department at Capgemini Invent in France and co-develop the Life Sciences in Switzerland.